Nervonik (Series A)

Traction: Nervonik completed the first-in-human clinical study of its PNS device at the end of last year.
Founders: Aydin Babakhani
Company Description: Nervonik is a startup focused on developing an opioid-free peripheral nerve stimulation (PNS) system designed to enhance therapy outcomes in the treatment of chronic pain. The device applies highly controlled electrical currents to peripheral nerves to modulate pain signals and provide pain relief.
Market: Chronic Pain Management
Location: Los Angeles, California, USA
Coinvestors: Foothill Ventures, Correlation Ventures